Ligand validation:6OWP

ETF: TRIFLUOROETHANOL

ETF is a Ligand Of Interest in 6OWP designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6OWP_ETF_A_404	98%	60%	0.061	0.983	0.48	1.05	-	-	0	0	100%	0.51
6OWP_ETF_B_404	97%	65%	0.06	0.976	0.68	0.67	-	-	0	0	100%	0.55
7UCA_ETF_A_404	99%	64%	0.05	0.979	0.72	0.65	-	-	0	0	100%	1
7UA6_ETF_A_404	98%	68%	0.055	0.977	0.85	0.4	-	-	0	0	100%	1
7UC9_ETF_A_404	98%	63%	0.057	0.975	0.84	0.57	-	-	0	0	100%	1
4DXH_ETF_A_378	96%	58%	0.058	0.969	0.79	0.82	-	-	0	0	100%	1
7UCU_ETF_A_404	96%	63%	0.06	0.967	0.87	0.54	-	-	0	0	100%	1
4NXY_ETF_A_201	96%	42%	0.06	0.969	1	1.23	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.